Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LP-184 by Starlight Therapeutics for Glioblastoma Multiforme (GBM): Likelihood of Approval
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
LP-184 by Starlight Therapeutics for Central Nervous System (CNS) Cancer: Likelihood of Approval
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Central Nervous System (CNS) Cancer. According...
LP-184 by Starlight Therapeutics for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM). According to...
LP-184 by Starlight Therapeutics for High-Grade Glioma: Likelihood of Approval
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for High-Grade Glioma. According to GlobalData, Phase...